Since a thrombectomy is performed in a certain percentage of PCI procedures, as procedure growth remained flat over the last few years, so have thrombectomy device sales. As procedure growth begins to stabilize, unit sales of thrombectomy devices will also rebound. Over the forecast period, the number thrombectomy devices sold for coronary applications is expected to increase. However, the price for a thrombectomy device has been decreasing at a higher rate than unit growth, resulting in a net decrease for the overall market.
Table of Contents
U.S. Interventional Cardiology Device Market OverviewCompetitive Analysis
Market Trends
Market Developments
Procedure Numbers
Procedure Codes Investigated
Markets Included
Key Report Updates
Version History
1. RESEARCH METHODOLOGY
Step 1: Project Initiation & Team Selection
Step 2: Prepare Data Systems and Perform Secondary Research
Step 3: Preparation for Interviews & Questionnaire Design
Step 4: Performing Primary Research
Step 5: Research Analysis: Establishing Baseline Estimates
Step 6: Market Forecasts and Analysis
Step 7: Identify Strategic Opportunities
Step 8: Final Review and Market Release
Step 9: Customer Feedback and Market Monitoring
2. DISEASE OVERVIEW
2.1 BASIC ANATOMY
2.2 DISEASE TREATMENTS AND DIAGNOSTICS
2.2.1 General Diagnostics
2.2.2 Coronary Artery Disease (CAD)
2.2.3 Myocardial Infarction (MI)
2.2.4 Angina Pectoris
2.3 PATIENT DEMOGRAPHICS
2.3.1 General Statistics
3. CORONARY THROMBECTOMY DEVICE MARKET
3.1 INTRODUCTION
3.1.1 Drug-Eluting Stents and Thrombosis Treatment
3.2 MARKET ANALYSIS AND FORECAST
3.3 DRIVERS AND LIMITERS
3.3.1 Market Drivers
3.3.2 Market Limiters
3.4 COMPETITIVE MARKET SHARE ANALYSIS
Abbreviations
Appendix I: Company Press Releases
List of Charts:
Chart 1 1: Interventional Cardiology Device Market by Segment, U.S., 2014 – 2024
Chart 1 2: Interventional Cardiology Device Market Overview, U.S., 2017 & 2024
Chart 3 1: Coronary Thrombectomy Device Market, U.S., 2014 – 2024
Chart 3 2: Leading Competitors, Coronary Thrombectomy Device Market, U.S., 2017
List of Figures:
Figure 1 1: Interventional Cardiology Device Market Share Ranking by Segment, U.S., 2017 (1 of 3)
Figure 1 2: Interventional Cardiology Device Market Share Ranking by Segment, U.S., 2017 (2 of 3)
Figure 1 3: Interventional Cardiology Device Market Share Ranking by Segment, U.S., 2017 (3 of 3)
Figure 1 4: Companies Researched in this Report, U.S., 2017
Figure 1 5: Factors Impacting the Interventional Cardiology Market by Segment, U.S. (1 of 3)
Figure 1 6: Factors Impacting the Interventional Cardiology Market by Segment, U.S. (2 of 3)
Figure 1 7: Factors Impacting the Interventional Cardiology Market by Segment, U.S. (3 of 3)
Figure 1 8: Recent Events in the Interventional Cardiology Market, U.S., 2014 – 2017
Figure 1 9: Interventional Cardiology Procedures Covered, U.S., 2017
Figure 1 10: Procedure Codes Investigated, U.S., 2017
Figure 1 11: Interventional Cardiology Markets Covered, U.S., 2017 (1 of 2)
Figure 1 12: Interventional Cardiology Markets Covered, U.S., 2017 (2 of 2)
Figure 1 13: Key Report Updates
Figure 1 14: Version History
Figure 3 1: Coronary Thrombectomy Device Market, U.S., 2014 – 2024
Figure 3 2: Drivers and Limiters, Coronary Thrombectomy Device Market, U.S., 2017
Figure 3 3: Leading Competitors, Coronary Thrombectomy Device Market, U.S., 2017
Figure 5 1: Press Release Summary
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Boston Scientific
- Abbott Laboratories
- Medtronic
- Philips
- Terumo
- Cardinal Health
- Merit Medical Systems
- Cook Medical
- Asahi Intecc
- Teleflex
- Cardiovascular Systems Inc.
- Galt Medical
- C.R. Bard
- Angiodynamics
- ACIST Medical Systems
- Infraredx
- Tryton Medical
- B. Braun
- Maquet
Please Note: Not all companies are currently active in every segment or sub-report from this suite.
